• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    10.27 Up 0.01(0.10%) May 22, 4:00PM EDT
    |After Hours : 10.27 0.00 (0.00%) May 22, 4:25PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 22,150   15,369   14,783   10,862  
    Cost of Revenue5,015  682  703  198  
    Gross Profit 17,135   14,687   14,080   10,664  
    Operating Expenses
    Research Development4,478  4,751  3,702  3,514  
    Selling General and Administrative18,806  17,323  11,289  28,139  
    Non Recurring -   -   -   -  
    Others4,144  536  536  617  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (10,293) 69,693   (1,447) (21,606)
    Income from Continuing Operations
    Total Other Income/Expenses Net72  77,642  22  31  
    Earnings Before Interest And Taxes(10,221)147,335  (1,425)(21,575)
    Interest Expense -   -   -   -  
    Income Before Tax(10,221)147,335  (1,425)(21,575)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(10,221)147,335  (1,425)(21,575)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (10,221) 69,719   (1,425) (21,575)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (10,221) 69,719   (1,425) (21,575)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.